Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.
2.

A period of immobility after remifentanil administration protects from nausea: an experimental randomized cross-over study.

Heuser F, Schulz CM, Hapfelmeier A, Lehnen N, Kochs EF, Wagner KJ.

BMC Anesthesiol. 2016 Oct 10;16(1):90.

3.

Reducing Fatal Opioid Overdose: Prevention, Treatment and Harm Reduction Strategies.

Hawk KF, Vaca FE, D'Onofrio G.

Yale J Biol Med. 2015 Sep 3;88(3):235-45. eCollection 2015 Sep. Review.

4.

Opioid-Induced Nausea Involves a Vestibular Problem Preventable by Head-Rest.

Lehnen N, Heuser F, Sağlam M, Schulz CM, Wagner KJ, Taki M, Kochs EF, Jahn K, Brandt T, Glasauer S, Schneider E.

PLoS One. 2015 Aug 27;10(8):e0135263. doi: 10.1371/journal.pone.0135263. eCollection 2015.

5.

The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute Pain.

Pergolizzi JV Jr, Taylor R Jr, Raffa RB.

Adv Ther. 2015 Jun;32(6):485-95. doi: 10.1007/s12325-015-0213-5. Epub 2015 May 31.

6.

A Model-Based Meta-analysis to Compare Efficacy and Tolerability of Tramadol and Tapentadol for the Treatment of Chronic Non-Malignant Pain.

Mercier F, Claret L, Prins K, Bruno R.

Pain Ther. 2014 Jun;3(1):31-44. doi: 10.1007/s40122-014-0023-5. Epub 2014 Feb 13.

7.

Daily average consumption of 2 long-acting opioids: an interrupted time series analysis.

Puenpatom RA, Szeinbach SL, Ma L, Ben-Joseph RH, Summers KH.

Am Health Drug Benefits. 2012 Jan;5(1):52-60.

8.

Changes in trends and pattern of strong opioid prescribing in primary care.

Zin CS, Chen LC, Knaggs RD.

Eur J Pain. 2014 Oct;18(9):1343-51. doi: 10.1002/j.1532-2149.2014.496.x. Epub 2014 Apr 22.

9.

Opioid therapy pharmacogenomics for noncancer pain: efficacy, adverse events, and costs.

Xu Y, Johnson A.

Pain Res Treat. 2013;2013:943014. doi: 10.1155/2013/943014. Epub 2013 Sep 18. Review.

10.

Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010.

Daubresse M, Chang HY, Yu Y, Viswanathan S, Shah ND, Stafford RS, Kruszewski SP, Alexander GC.

Med Care. 2013 Oct;51(10):870-8. doi: 10.1097/MLR.0b013e3182a95d86.

11.

Opioids for chronic non-cancer pain: a protocol for a systematic review of randomized controlled trials.

Busse JW, Schandelmaier S, Kamaleldin M, Hsu S, Riva JJ, Vandvik PO, Tsoi L, Lam T, Ebrahim S, Johnston B, Oliveri L, Montoya L, Kunz R, Malandrino A, Bhatnagar N, Mulla SM, Lopes LC, Soobiah C, Wong A, Buckley N, Sessler D, Guyatt GH.

Syst Rev. 2013 Aug 21;2:66. doi: 10.1186/2046-4053-2-66.

12.

Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety?

Kissin I.

J Pain Res. 2013 Jul 4;6:513-29. doi: 10.2147/JPR.S47182. Print 2013.

13.

Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain.

Dobscha SK, Morasco BJ, Duckart JP, Macey T, Deyo RA.

Clin J Pain. 2013 Feb;29(2):102-8. doi: 10.1097/AJP.0b013e3182490bdb.

15.

Trends in opioid use and dosing among socio-economically disadvantaged patients.

Gomes T, Juurlink DN, Dhalla IA, Mailis-Gagnon A, Paterson JM, Mamdani MM.

Open Med. 2011;5(1):e13-22. Epub 2011 Jan 25.

16.

Treatment of pain in children after limb-sparing surgery: an institution's 26-year experience.

Anghelescu DL, Oakes LL, Hankins GM.

Pain Manag Nurs. 2011 Jun;12(2):82-94. doi: 10.1016/j.pmn.2010.02.002. Epub 2010 Sep 20.

17.

Prescription opioid abuse, pain and addiction: clinical issues and implications.

Ling W, Mooney L, Hillhouse M.

Drug Alcohol Rev. 2011 May;30(3):300-5. doi: 10.1111/j.1465-3362.2010.00271.x. Review.

18.

Prescription drug abuse: epidemiology, regulatory issues, chronic pain management with narcotic analgesics.

Manubay JM, Muchow C, Sullivan MA.

Prim Care. 2011 Mar;38(1):71-90, vi. doi: 10.1016/j.pop.2010.11.006. Review.

19.

Trends in long-term opioid therapy for chronic non-cancer pain.

Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, Campbell CI, Merrill JO, Silverberg MJ, Banta-Green C, Weisner C.

Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1166-75. doi: 10.1002/pds.1833.

20.

Markers of abuse liability of short- vs long-acting opioids in chronic pain patients: a randomized cross-over trial.

Wilsey BL, Fishman S, Li CS, Storment J, Albanese A.

Pharmacol Biochem Behav. 2009 Nov;94(1):98-107. doi: 10.1016/j.pbb.2009.07.014. Epub 2009 Aug 4.

Supplemental Content

Support Center